Search results for "time factor"

showing 10 items of 3219 documents

Real time analysis of volatile organic compounds (VOCs) in centenarians.

2014

Centenarians are a model to study human longevity and the physiological process of aging. A plethora of studies on this model show the complexity of the system. Laboratory studies fail to find a biomarker of senescence. The real time exhaled breath volatile organic compounds (VOCs) has been suggested as a new biomarker to detect and monitor physiological processes in the respiratory system. VOCs exhaled by centenarians have not been studied in the general population and across-age-groups. In the present study we investigated, in real time, the breath properties and VOC exhaled content in healthy centenarians as compared with non-centenarian seniors and young healthy subjects. We found disti…

Pulmonary and Respiratory MedicineAdultTime FactorsPhysiologymedia_common.quotation_subjectPopulationLongevityToxicologyYoung AdultHumanseducationReal time analysismedia_commonAged 80 and overeducation.field_of_studyVolatile Organic CompoundsChemistryGeneral NeuroscienceRespirationHealthy subjectsLongevityBiomarkerBreath TestsEnvironmental chemistryHuman longevityCentenarianRespiratory physiologyneurobiology
researchProduct

Prenatal tobacco smoke exposure increases hospitalizations for bronchiolitis in infants

2015

Background Tobacco smoke exposure (TSE) is a worldwide health problem and it is considered a risk factor for pregnant women’s and children’s health, particularly for respiratory morbidity during the first year of life. Few significant birth cohort studies on the effect of prenatal TSE via passive and active maternal smoking on the development of severe bronchiolitis in early childhood have been carried out worldwide. Methods From November 2009 to December 2012, newborns born at ≥33 weeks of gestational age (wGA) were recruited in a longitudinal multi-center cohort study in Italy to investigate the effects of prenatal and postnatal TSE, among other risk factors, on bronchiolitis hospitalizat…

Pulmonary and Respiratory MedicineAdultmedicine.medical_specialtyPediatricsTime FactorsTime FactorOffspringLongitudinal StudieRisk AssessmentTobacco smoke exposure Pregnancy Infant Bronchiolitis Hospitalization Risk factorBronchiolitis; Hospitalization; Infant; Pregnancy; Risk factor; Tobacco smoke exposure; Adult; Age Factors; Bronchiolitis; Female; Humans; Infant; Infant Newborn; Inhalation Exposure; Italy; Longitudinal Studies; Maternal Exposure; Pregnancy; Risk Assessment; Risk Factors; Smoking; Time Factors; Tobacco Smoke Pollution; Hospitalization; Prenatal Exposure Delayed Effects; Pulmonary and Respiratory MedicineRisk FactorsPregnancymedicineHumansAge FactorLongitudinal StudiesBronchiolitiRisk factorIntensive care medicineInhalation exposurePregnancyInhalation Exposurebusiness.industryResearchSmokingAge FactorsInfant NewbornGestational ageInfantNewbornmedicine.diseaseHospitalizationItalyBronchiolitisMaternal ExposureTobacco smoke exposurePrenatal Exposure Delayed EffectsBronchiolitisFemaleTobacco Smoke PollutionRisk factorRisk assessmentbusinessHumanCohort study
researchProduct

New 3-zone hybrid graft : First-in-man experience in acute type I dissection

2019

Abstract Objective Acute type I aortic dissection (AAD) represents a surgical emergency with time-dependent evolving complications. Frozen elephant trunk (FET) enables false lumen exclusion downstream but is still debated in AAD due to its greater dimension of surgery. To combine the benefits of fast proximal repair with the FET benefits, a 3-zone hybrid graft was developed consisting of an ascending polyester portion, an arch noncovered stent, and a descending stent graft. Mid-term results of this new technique are presented. Methods A total of 6 patients (age mean 69 years) with type I AAD in critical status (Penn classification B n = 5, BC n = 1) were operated between July 2016 and April…

Pulmonary and Respiratory MedicineAortic archAdultMalemedicine.medical_specialtyTime FactorsElephant trunksmedicine.medical_treatmentMedizinLumen (anatomy)030204 cardiovascular system & hematologyProsthesis Design03 medical and health sciencesBlood Vessel Prosthesis Implantation0302 clinical medicinemedicine.arteryMedicineHumansSurgical emergencyCerebral perfusion pressureAgedAortic dissectionbusiness.industryEndovascular ProceduresStentmedicine.diseaseSurgeryAortic AneurysmBlood Vessel ProsthesisStenosisAortic DissectionTreatment Outcome030228 respiratory systemAcute DiseaseSurgeryStentsCardiology and Cardiovascular Medicinebusiness
researchProduct

Value of echocardiography in patient follow-up after surgically corrected type A aortic dissection.

2001

Background To identify patients (pts) at risk of late complications, follow-up after surgery for type A aortic dissection is essential. We assessed the value of echocardiography to monitor patients after surgery for type A aortic dissection. Methods 80 out of 108 pts operated between 1989 and 1999 for type A aortic dissection survived surgery. 62 pts with at least one TEE, CT or MRI examinations during follow-up were included in this study. All pts had transthoracic echocardiography (TTE), 53 transesophageal echocardiography (TEE), 51 had CT, and 39 had MRI. Results At the first follow-up, 12 of 48 pts with aortic valve sparing surgery presented with aortic insufficiency >I degrees detected…

Pulmonary and Respiratory MedicineAortic archAortic valveAdultMaleReoperationmedicine.medical_specialtyTime FactorsAortic Valve InsufficiencySeverity of Illness IndexDiagnosis DifferentialAortic aneurysmAneurysmmedicine.arteryGermanymedicineHumansAgedAortic dissectionAged 80 and overPostoperative Caremedicine.diagnostic_testbusiness.industryMagnetic resonance imagingStroke VolumeStroke volumeMiddle Agedmedicine.diseaseImage EnhancementMagnetic Resonance ImagingSurvival AnalysisAortic AneurysmAortic Dissectionmedicine.anatomical_structureEchocardiographyAortic Valvecardiovascular systemDisease ProgressionSurgeryFemaleRadiologyDifferential diagnosisCardiology and Cardiovascular MedicinebusinessTomography X-Ray Computedhuman activitiesFollow-Up StudiesThe Thoracic and cardiovascular surgeon
researchProduct

Mid-term results of bicuspid aortic valve repair guided by morphology and function assessment.

2016

Bicuspid aortic valve (BAV) is frequently associated with aortic insufficiency (AI) due to cusp disease and/or aortic root dilatation. Based on functional classification and morphology, a systematic surgical approach was used for aortic valve repair (AVr).From 2004 to 2014, 152 consecutive patients (mean age 55 ± 7 years) with BAV underwent AVr with or without concomitant aortic root surgery. Cusp pathology was treated with central plication in 60 (39.5%) patients, free edge reinforcement in 45 (29.6%), triangular resection in 28 (18.4%) and pericardial patch in 19 (12.5%). Aortic root dilatation was corrected with valve sparing reimplantation in 65 patients. Mean follow-up was 68 ± 36 mont…

Pulmonary and Respiratory MedicineAortic valveMalemedicine.medical_specialtyTime FactorsHeart VentriclesMid term resultsHeart Valve DiseasesAortic root dilatation030204 cardiovascular system & hematologyPreoperative careVentricular Function Left03 medical and health sciences0302 clinical medicineAortic valve repairBicuspid aortic valvePostoperative ComplicationsBicuspid Aortic Valve DiseaseRecurrenceInternal medicineMedicineHumansHospital MortalityRetrospective StudiesPericardial patchbusiness.industryIncidenceMiddle Agedmedicine.diseaseSurvival Ratemedicine.anatomical_structureTreatment Outcome030228 respiratory systemItalyEchocardiographyConcomitantAortic Valvecardiovascular systemCardiologySurgeryFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesInteractive cardiovascular and thoracic surgery
researchProduct

Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?

2011

Objective: Baseline inhaled corticosteroid (ICS) dose may be a factor for prescribers to consider when they select a budesonide/formoterol maintenance and reliever therapy regimen for symptomatic asthmatics. Methods: A 6-month randomized study compared two maintenance doses of budesonide/formoterol 160/4.5 µg, 1 × 2 and 2 × 2, plus as needed, in 8424 asthma patients with symptoms when treated with ICS ± an inhaled long-acting β2-agonist (LABA). In the total study population, 1339 (17%) were high-dose ICS (HD) users (≥1600 µg/day budesonide). This HD stratum was compared with the rest of the study population, divided into low-dose (LD; 400 µg/day) and medium-dose strata (MD; 401–1599 µg/day…

Pulmonary and Respiratory MedicineBudesonideAdultMalemedicine.medical_specialtyTime FactorsAdolescentmedicine.drug_classSeverity of Illness Indexlaw.inventionYoung AdultRandomized controlled triallawAdrenal Cortex HormonesInternal medicineSurveys and QuestionnairesAdministration InhalationmedicineBudesonide Formoterol Fumarate Drug CombinationHumansPharmacology (medical)Anti-Asthmatic AgentsBudesonideAsthmaAgedlcsh:RC705-779Aged 80 and overDose-Response Relationship Drugbusiness.industrylcsh:Diseases of the respiratory systemMiddle Agedmedicine.diseaseAsthmaRegimenDrug CombinationsTreatment OutcomeBudesonide/formoterolAsthma Control QuestionnaireEthanolaminesAnesthesiaCorticosteroidFemaleFormoterolbusinessmedicine.drugTherapeutic advances in respiratory disease
researchProduct

Towards the determination of isoprene in human breath using substrate-integrated hollow waveguide mid-infrared sensors

2014

Selected volatile organic compounds (VOCs) in breath may be considered biomarkers if they are indicative of distinct diseases or disease states. Given the inherent molecular selectivity of vibrational spectroscopy, infrared sensing technologies appear ideally suitable for the determination of endogenous VOCs in breath. The aim of this study was to determine that mid-infrared (MIR; 3-20 µm) gas phase sensing is capable of determining isoprene in exhaled breath as an exemplary medically relevant VOC by hyphenating novel substrate-integrated hollow waveguides (iHWG) with a likewise miniaturized preconcentration system. A compact preconcentrator column for sampling isoprene from exhaled breath …

Pulmonary and Respiratory MedicineDetection limitTime FactorsInfrared RaysTemperatureAnalytical chemistryInfrared spectroscopySignal Processing Computer-AssistedBiosensing TechniquesSubstrate (electronics)Reference StandardsHollow waveguidechemistry.chemical_compoundHemiterpenesBreath TestsBreath gas analysischemistryPentanesTemporal resolutionCalibrationButadienesCalibrationHumansIsopreneJournal of Breath Research
researchProduct

Invited commentary.

2007

Pulmonary and Respiratory MedicineHeart Defects CongenitalMalePacemaker ArtificialTime Factorsbusiness.industryCardiac Pacing ArtificialInfant NewbornInfantRisk AssessmentProsthesis ImplantationTreatment OutcomeMedicineHumansSurgeryFemaleCardiology and Cardiovascular MedicinebusinessClassicsFollow-Up StudiesThe Annals of thoracic surgery
researchProduct

Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis.

1992

An activation of T-cells that is restricted to the lung has been demonstrated in pulmonary sarcoidosis. The role of blood monocytes (MO) and alveolar macrophages (AM) in this concept of compartmentalized inflammation has not yet been evaluated. In order to elucidate this question, we measured the release of tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1) by peripheral blood mononuclear cells (PBMNC) and AM in 43 patients with sarcoidosis (32 with active, 11 with inactive disease) without therapy and correlated the spontaneous monokine release to parameters of the T-cell alveolitis and the course of the disease. TNF alpha as well as IL-1 were spontaneously released by AM of …

Pulmonary and Respiratory MedicineInterleukin 2Lung Diseasesmedicine.medical_specialtyTime FactorsSarcoidosisLung Diseases/metabolism610 MedizinInflammationSarcoidosis/metabolismLymphocyte ActivationMacrophages Alveolar/secretionPeripheral blood mononuclear cellMonocytesInterleukin-1/secretionInternal medicineMacrophages AlveolarmedicineMacrophageHumansddc:610Receptors Interleukin-2/metabolismTumor Necrosis Factor-alpha/secretionbusiness.industryTumor Necrosis Factor-alphaMonocyteLeukocytes Mononuclear/secretionMonocytes/immunologyReceptors Interleukin-2Macrophage ActivationMonokinemedicine.anatomical_structureEndocrinologyImmunologyAlveolar macrophageLeukocytes MononuclearInterleukin-2Tumor necrosis factor alphamedicine.symptomInterleukin-2/secretionbusinessmedicine.drugInterleukin-1The American review of respiratory disease
researchProduct

[Methodologic and clinical aspects of the determination of glutathione in induced sputum in bronchopulmonary diseases].

2003

Pulmonary and Respiratory MedicineLung DiseasesPathologymedicine.medical_specialtyTime Factorsbusiness.industryRespiratory Tract DiseasesSputumInduced sputumReproducibility of ResultsBronchial DiseasesGlutathioneGlutathioneSpecimen Handlingchemistry.chemical_compoundchemistryBronchopulmonary diseasesImmunologymedicineHumansbusinessPneumologie (Stuttgart, Germany)
researchProduct